ASP Isotopes Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $30.9M+644.5% YoYTTM through 30 Jun 2026
Net Income -$117.3MTTM through 30 Jun 2026
Free Cash Flow -$83.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 14.3% |
| EBITDA Margin | -303.3% |
| Operating Margin | -251.7% |
| Net Margin | -380.3% |
Returns
-58.6%ROE
-29.8%ROA
Balance Sheet Health
Debt / Equity0.86x
Current Ratio4.38x
Net Debt-$75.1Mnet cash position
Cash & Equivalents$219.6M
Quality Metrics
Altman Z-Score0.22
Piotroski F-Score2 / 9
FCF Margin-270.9%
Rule of 40-269.5
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $23.8M
Diluted EPS-$1.27TTMFY2025: $-1.93
Dividend
No dividend
Capital Allocation
R&D Spend$22M
Capex Intensity51.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Specialized Isotopes and Services | $5.7M | +46.2% | View detailsTargeting first commercial shipments of Silicon-28, Carbon-14, and Ytterbium-176 in 2026. |
| Construction Services (Skyline) | $18.1M | View detailsSkyline was deconsolidated on March 29, 2026, and is reported as discontinued operations starting Q1 2026. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.